Calcium channel blockers in thetreatment of hypertension and prevention of cardiovascular disease: Results from major clinical trials
- 31 December 2004
- journal article
- Published by Elsevier BV in Clinical Cornerstone
- Vol. 6 (4), 53-63
- https://doi.org/10.1016/s1098-3597(04)80078-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Calcium channel blockers: an updateAmerican Journal Of Medicine, 2004
- A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery DiseaseJAMA, 2003
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 ReportJAMA, 2003
- Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) TrialJAMA, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) studyThe Lancet, 2000
- Major Cardiovascular Events in Hypertensive Patients Randomized to Doxazosin vs Chlorthalidone: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2000
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsThe New England Journal of Medicine, 2000
- Calcium antagonists and mortality risk in men and women with hypertension in the Framingham Heart Study.Archives of Internal Medicine, 1998
- Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertensionThe Lancet, 1997